Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil vs Sildenafil on Inflammatory Markers in Erectile Dysfunction
NCT05466695Phase 1Unknown
- Sponsor
- Assiut University
- Start
- Aug 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in erectile dysfunction (ED) comparing Tadalafil 5mg Group with Sildenafil 25mg Group (2 arms). Primary endpoints: Neutrophil-Lymphocyte Ratio at 2 months, Platelet-Lymphocyte Ratio at 2 months and 1 more. Status: unknown.
02
Drugs
tadalafilsildenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT05466695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05466695.